Sandhill Capital Partners LLC Vertex Pharmaceuticals Inc Transaction History

Sandhill Capital Partners LLC

  • $1.26 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$181.39 - $202.99 $29.6 Million - $33.1 Million
-163,114 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$187.49 - $221.1 $3.95 Million - $4.66 Million
-21,061 Reduced 11.44%
163,114 $32.9 Million
Q1 2021

May 13, 2021
BUY
$207.02 - $241.31 $38.1 Million - $44.4 Million
184,175 New
184,175 $39.6 Million

Others Institutions Holding VRTX

# of Institutions
1,716
Shares Held
225M
Call Options Held
1.19M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sandhill Capital Partners LLC Portfolio

Follow Sandhill Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandhill Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sandhill Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email